Financial Ratios | Wockhardt Ltd. | R Wadiwala Securities Pvt Ltd

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE1339.75-1.95 (-0.15 %)
PREV CLOSE (Rs.) 1341.70
OPEN PRICE (Rs.) 1337.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16509
TODAY'S LOW / HIGH (Rs.)1336.45 1353.65
52 WK LOW / HIGH (Rs.)1109.6 1870
NSE1341.00-0.2 (-0.01 %)
PREV CLOSE( Rs. ) 1341.20
OPEN PRICE (Rs.) 1341.20
BID PRICE (QTY) 1341.00 (299)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 190798
TODAY'S LOW / HIGH(Rs.) 1336.00 1353.80
52 WK LOW / HIGH (Rs.)1110.05 1868.8

Financial Ratios

Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)-2.90-30.06-38.82-16.9462.36
   CEPS(Rs)9.88-16.17-25.69-2.22-4.27
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)267.96217.27231.81266.04304.36
   Tax Rate(%)-256.25-12.380.4832.1247.71
Margin Ratios
   Core EBITDA Margin(%)10.161.082.365.81-1.36
   EBIT Margin(%)6.15-3.19-7.54-2.18-6.88
   Pre Tax Margin(%)-0.41-11.65-14.60-8.01-12.25
   PAT Margin (%)-1.47-13.09-14.53-5.44-6.41
   Cash Profit Margin (%)4.14-6.91-8.66-0.62-1.10
Performance Ratios
   ROA(%)-0.78-6.67-8.42-3.71-3.93
   ROE(%)-1.48-14.12-17.32-7.77-9.92
   ROCE(%)4.07-2.15-5.88-1.96-5.50
   Asset Turnover(x)0.530.510.580.680.61
   Sales/Fixed Asset(x)0.670.630.730.880.75
   Working Capital/Sales(x)9.16-5.02-2.81-6.73-5.52
Efficiency Ratios
   Fixed Capital/Sales(x)1.491.581.371.141.33
   Receivable days60.3671.6373.2565.2985.04
   Inventory Days64.4265.7160.9555.7659.63
   Payable days218.94255.81293.71232.91255.87
Valuation Parameters
   PER(x)0.000.000.000.006.12
   PCE(x)144.15-36.09-5.99-118.71-89.37
   Price/Book(x)5.312.690.660.991.36
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)8.213.781.501.632.44
   EV/Core EBITDA(x)54.3686.6417.8516.5295.62
   EV/EBIT(x)103.92-91.91-12.36-46.92-20.68
   EV/CE(x)3.981.930.760.690.89
   M Cap / Sales7.663.210.841.181.68
Growth Ratio
   Net Sales Growth(%)7.655.55-17.9319.28-4.78
   Core EBITDA Growth(%)272.95-45.29-29.87360.87-56.28
   EBIT Growth(%)306.9664.29-187.5064.89-381.15
   PAT Growth(%)87.9223.99-122.586.06-115.30
   EPS Growth(%)90.3522.55-129.10-127.171097.71
Financial Stability Ratios
   Total Debt/Equity(x)0.430.630.570.490.70
   Current Ratio(x)1.210.740.560.760.73
   Quick Ratio(x)0.850.510.370.520.47
   Interest Cover(x)0.94-0.38-1.07-0.37-1.28
   Total Debt/Mcap(x)0.080.240.850.490.51